Legal Representation
Attorney
Alexandra MacKay
USPTO Deadlines 3 active 3 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OPPOSITION
Notice of Publication |
NPUB | Aug 02, 2018 | 2531 days overdue | Medium | Until Sep 02, 2018 |
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Jun 23, 2020 | 1840 days overdue | Critical | Until Sep 23, 2020 |
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Jun 23, 2020 | 1840 days overdue | Critical | Until Sep 23, 2020 |
Application History
25 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 13, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Oct 12, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Mar 23, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
Mar 23, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
Mar 23, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 21, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Mar 18, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Feb 28, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Feb 28, 2020 | IUAF | S | USE AMENDMENT FILED |
Jul 27, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jul 25, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 25, 2019 | EXT2 | S | SOU EXTENSION 2 FILED |
Jul 25, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED |
Oct 17, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 15, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 15, 2018 | EXT1 | S | SOU EXTENSION 1 FILED |
Oct 15, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED |
Aug 30, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jul 3, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 3, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 13, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
May 25, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 23, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 16, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Feb 12, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical and biochemical products for the treatment of skin diseases, lung diseases, fibrotic diseases, pain and other disease areas
First Use Anywhere:
Feb 24, 2020
First Use in Commerce:
Feb 24, 2020
Classification
International Classes
005